Relating to the implementation of student and family engagement plans by school districts.
Relating to the administration of opioid antagonists by a school nurse or school district administrative personnel at public school campuses.
Relating to the administration of opioid antagonists by a school nurse at public school campuses.
Relating to a policy adopted by school districts allowing parent volunteers on school district campuses.
Relating to the use of opioid antagonists on the campuses of public and private schools and institutions of higher education and at or in transit to or from off-campus school events.
Relating to the maintenance, administration, and disposal of opioid antagonists at school district campuses serving students in grades six and above.
Relating to the inclusion of a school safety domain for evaluating districts and campuses under the public school accountability system.
Relating to permissible accountability interventions for certain school districts with low-performing campuses.
Relating to the use of glucagon medication on certain public and private school campuses.
Relating to an annual student discipline review by the commissioner of education and student discipline plans submitted by public schools.